EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Drug Transporter P-Glycoprotein and Its Impact on Ceramide Metabolism—An Unconventional Ally in Cancer Treatment

Johnson Ung iD, Miki Kassai, Su-Fern Tan, Thomas P Loughran, David J Feith iD, Myles C Cabot

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25189825 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Johnson Ung und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA. Hauptthemen laut MEDLINE: Ceramides, Neoplasms, Drug Resistance, Neoplasm, ATP Binding Cassette Transporter, Subfamily B, Member 1. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH/NCI, the National Institutes of Health, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor-suppressor sphingolipid ceramide is recognized as a key participant in the cytotoxic mechanism of action of many types of chemotherapy drugs, including anthracyclines, Vinca alkaloids, the podophyllotoxin etoposide, taxanes, and the platinum drug oxaliplatin. These drugs can activate de novo synthesis of ceramide or stimulate the production of ceramide via sphingomyelinases to limit cancer cell survival. On the contrary, dysfunctional sphingolipid metabolism, a prominent factor in cancer survival and therapy resistance, blunts the anticancer properties of ceramide-orchestrated cell death pathways, especially apoptosis. Although P-glycoprotein (P-gp) is famous for its role in chemotherapy resistance, herein, we propose alternate interpretations and discuss the capacity of this multidrug transporter as a “ceramide neutralizer”, an unwelcome event, highlighting yet another facet of P-gp’s versatility in drug resistance. We introduce sphingolipid metabolism and its dysfunctional regulation in cancer, present a summary of factors that contribute to chemotherapy resistance, explain how P-gp “neutralizes” ceramide by hastening its glycosylation, and consider therapeutic applications of the P-gp-ceramide connection in the treatment of cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeramidesNeoplasmsDrug Resistance, NeoplasmATP Binding Cassette Transporter, Subfamily B, Member 1Antineoplastic AgentsHumansAnimalsSphingolipids

Stichwörter der Autor:innen

P-glycoproteincancer drug resistanceceramidesphingolipids

Substanzen

CeramidesATP Binding Cassette Transporter, Subfamily B, Member 1Antineoplastic AgentsSphingolipids

Autor:innen und Institutionen

  • Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
  • Department of Biochemistry and Molecular Biology, Brody School of Medicine, East Carolina University, The East Carolina Diabetes and Obesity Institute, Greenville, NC 27834, USA.
  • University of Virginia Cancer Center, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
  • Department of Medicine, Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

ORCID-Profile: Johnson Ung, David J Feith

Förderung

  • NCI NIH HHS
  • NIH/NCI
  • the National Institutes of Health, National Cancer Institute

Zitieren

APA

Ung, J., Kassai, M., Tan, S. F., Loughran, T. P., Feith, D. J., & Cabot, M. C. (2024). The Drug Transporter P-Glycoprotein and Its Impact on Ceramide Metabolism—An Unconventional Ally in Cancer Treatment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25189825

Vancouver

Ung J, Kassai M, Tan SF, Loughran TP, Feith DJ, Cabot MC. The Drug Transporter P-Glycoprotein and Its Impact on Ceramide Metabolism—An Unconventional Ally in Cancer Treatment. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25189825

BibTeX
@article{Ung2024,
  author = {Ung, Johnson and Kassai, Miki and Tan, Su-Fern and Loughran, Thomas P and Feith, David J and Cabot, Myles C},
  title = {The Drug Transporter P-Glycoprotein and Its Impact on Ceramide Metabolism—An Unconventional Ally in Cancer Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25189825}
}
Kostenlos starten →